Nothing Special   »   [go: up one dir, main page]

Ballester López, 2019 - Google Patents

Novel players in COPD and their molecular implication in the disease immunopathology

Ballester López, 2019

View PDF
Document ID
8368185409666584774
Author
Ballester López C
Publication year

External Links

Snippet

COPD is currently the third leading cause of death worldwide with 10% of people past forty affected [1, 2]. Exposure to environmental particles, especially cigarette smoke, is the most common cause of COPD. These patients exhibit a progressive airflow obstruction provoked …
Continue reading at edoc.ub.uni-muenchen.de (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Park et al. IL-1-IL-17 signaling axis contributes to fibrosis and inflammation in two different murine models of systemic sclerosis
Lichtenberger et al. Epidermal EGFR controls cutaneous host defense and prevents inflammation
Liu et al. Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases
Qin et al. Stimulation of TLR4 attenuates Alzheimer’s disease–related symptoms and pathology in tau-transgenic mice
Jia et al. Cholesterol metabolism promotes B‐cell positioning during immune pathogenesis of chronic obstructive pulmonary disease
Chen et al. CREB binding protein is required for both short-term and long-term memory formation
Kedzierski et al. Suppressor of cytokine signaling (SOCS) 5 ameliorates influenza infection via inhibition of EGFR signaling
Amin et al. Role of eosinophil granulocytes in allergic airway inflammation endotypes
Gour et al. Dysregulated invertebrate tropomyosin–dectin-1 interaction confers susceptibility to allergic diseases
Song et al. Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis
Shen et al. Role of aquaporin 5 in antigen‐induced airway inflammation and mucous hyperproduction in mice
Ballester-López et al. The Notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary disease
Cai et al. FOXP3+ macrophage represses acute ischemic stroke-induced neural inflammation
Stärkel et al. Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis
Trivedi et al. Targeting phospholipase D4 attenuates kidney fibrosis
Katzen et al. Disruption of proteostasis causes IRE1 mediated reprogramming of alveolar epithelial cells
Agostinis et al. The inflammatory feed-forward loop triggered by the complement component C3 as a potential target in endometriosis
Gon et al. NDRG1 is important to maintain the integrity of airway epithelial barrier through claudin‐9 expression
Liu et al. TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase
Kwon et al. Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma
Ballester López Novel players in COPD and their molecular implication in the disease immunopathology
López Novel players in COPD and their molecular implication in the disease immunopathology
Natarajan et al. Aberrant mitochondrial DNA synthesis in macrophages exacerbates inflammation and atherosclerosis
US20210252003A1 (en) Protein Kinase RNA-Like Endoplasmic Reticulum Kinase (PERK) Inhibitors for Prevention and/or Treatment of Lung Injury and/or Inflammation
WO2023077234A1 (en) A method of treating depression by immune modulation